Antibacterial co-formulated drug with the broadest spectrum of action. The coverage includes the majority of known representatives of gram-positive, gram-negative, anaerobic, atypical pathogens and protozoa.
The unparalleled spectrum of action can effect microorganisms empirically (without preliminary microbiological studies), and makes it possible to use the drug as monotherapy of coinfections (when there are several pathogens).
Due to the long half-life, Grandazol is administered once daily.
Tajikistan, Turkmenistan, Uzbekistan, Ukraine.
- Rheosorbilact improves the efficacy of empirical therapy for pelvic inflammatory disease (a case report)
- The ways to ameliorate the efficiency of treatment for women with pelvic inflammatory disease
- Efficacy evaluation of Grandazol in the treatment of male genital organs trichomonal inflammatory disorders